Get started
BEXIMCO PHARMACEUTICALS LTD BEXIMCO PHARMACEUTICALS LTD BEXIMCO PHARMACEUTICALS LTD

BEXIMCO PHARMACEUTICALS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BXPHARMA chart


Full chart

BXPHARMA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪37.92 B‬ BDT
Dividend yield (indicated)
4.71%
Price to earnings Ratio (TTM)
6.37
Basic EPS (TTM)
13.35 BDT
Net income (FY)
‪5.83 B‬ BDT
Revenue (FY)
‪44.39 B‬ BDT
Shares float
‪431.77 M‬
Beta (1Y)
0.72

Employees


Employees (FY)
‪1.12 K‬
Change (1Y)
+112 +11.09%
Revenue / Employee (1Y)
‪39.56 M‬ BDT
Net income / Employee (1Y)
‪5.20 M‬ BDT

About BEXIMCO PHARMACEUTICALS LTD


Sector
Health Technology
CEO
Iqbal Ahmed
Headquarters
Dhaka
Website
beximcopharma.com
Founded
1976
ISIN
BD0453BXPH04
FIGI
BBG000C2D3N5
Beximco Pharmaceuticals Ltd. engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. Its products include solid, liquid, cream, and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company was founded by Ahmed Sohail Fasihur Rahman and Ahmed Salman Fasiur Rahman in 1976 and is headquartered in Dhaka, Bangladesh.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BXPHARMA news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BXPHARMA is 83.10 BDT — it hasn't changed in the past 24 hours. Watch BEXIMCO PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on DSEBD exchange BEXIMCO PHARMACEUTICALS LTD stocks are traded under the ticker BXPHARMA.
BXPHARMA stock has fallen by −1.16% compared to the previous week, the month change is a −2.19% fall, over the last year BEXIMCO PHARMACEUTICALS LTD has showed a −43.16% decrease.
We've gathered analysts' opinions on BEXIMCO PHARMACEUTICALS LTD future price: according to them, BXPHARMA price has a max estimate of 157.71 BDT and a min estimate of 157.71 BDT. Watch BXPHARMA chart and read a more detailed BEXIMCO PHARMACEUTICALS LTD stock forecast: see what analysts think of BEXIMCO PHARMACEUTICALS LTD and suggest that you do with its stocks.
BXPHARMA reached its all-time high on Oct 6, 2021 with the price of 255.40 BDT, and its all-time low was 30.59 BDT and was reached on May 19, 2014. View more price dynamics on BXPHARMA chart.
See other stocks reaching their highest and lowest prices.
BXPHARMA stock is 3.62% volatile and has beta coefficient of 0.72. Track BEXIMCO PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is BEXIMCO PHARMACEUTICALS LTD there?
Today BEXIMCO PHARMACEUTICALS LTD has the market capitalization of ‪37.92 B‬, it has increased by 0.84% over the last week.
Yes, you can track BEXIMCO PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
BEXIMCO PHARMACEUTICALS LTD is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
BXPHARMA net income for the last quarter is ‪1.68 B‬ BDT, while the quarter before that showed ‪1.48 B‬ BDT of net income which accounts for 13.66% change. Track more BEXIMCO PHARMACEUTICALS LTD financial stats to get the full picture.
Yes, BXPHARMA dividends are paid annually. The last dividend per share was 4.00 BDT. As of today, Dividend Yield (TTM)% is 4.71%. Tracking BEXIMCO PHARMACEUTICALS LTD dividends might help you take more informed decisions.
BEXIMCO PHARMACEUTICALS LTD dividend yield was 3.45% in 2024, and payout ratio reached 30.61%. The year before the numbers were 2.39% and 33.84% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪1.12 K‬ employees. See our rating of the largest employees — is BEXIMCO PHARMACEUTICALS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEXIMCO PHARMACEUTICALS LTD EBITDA is ‪10.55 B‬ BDT, and current EBITDA margin is 23.19%. See more stats in BEXIMCO PHARMACEUTICALS LTD financial statements.
Like other stocks, BXPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEXIMCO PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEXIMCO PHARMACEUTICALS LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEXIMCO PHARMACEUTICALS LTD stock shows the sell signal. See more of BEXIMCO PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.